This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The UAB Research Foundation (The University of Alabama at Birmingham), The United States of America, as Represented by the Secretary, Department of Health and Human Services, Vanderbilt University. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 641 
2 out of 3,696 
2 out of 1,221 
Years Active: 2023-2025
Title: John Knight: Innovator in Hyperoxaluria Treatment
Introduction
John Knight is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of medicine, particularly in the treatment of hyperoxaluria. With a total of 2 patents, his work focuses on innovative methods to address this challenging condition.
Latest Patents
Knight's latest patents involve treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase. The disclosures provide methods for treating patients suffering from primary hyperoxaluria or idiopathic hyperoxaluria. This involves administering a therapeutically effective amount of specific compounds that act as lactate dehydrogenase inhibitors. These compounds are crucial in inhibiting the conversion of glyoxylate to oxalate. When administered to patients with elevated oxalate levels, such as those with PH types 1, 2, or 3, these compounds can prevent or significantly reduce the buildup of oxalate in the kidneys, bladder, urinary tract, and other parts of the body.
Career Highlights
Throughout his career, John Knight has worked with esteemed institutions such as Vanderbilt University and the UAB Research Foundation. His research and innovations have contributed to advancements in medical treatments and have the potential to improve the quality of life for many patients.
Collaborations
Knight has collaborated with notable colleagues, including Matthew E. Hall and Daniel Jason Urban. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.
Conclusion
John Knight's contributions to the treatment of hyperoxaluria through his patents and collaborations highlight his role as a significant innovator in medicine. His work continues to pave the way for advancements in patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile